NeOnc Technologies Holdings is trading 5.04% up at $2.66 as of 10:45 a.m. ET on October 9, 2026, amid possible support from biotech strength; no direct cause has been established. - No confirmed company announcement dated October 9 explains the move; major-index gains are modest. - The November 17 FDA meeting regarding NEO212 was previously announced, not a new catalyst for this session. - Shares closed at $2.53 on October 8 after several recent declines.